ReviewFrontiers in cardiovascular medicine2026
The predictive value of combining CAAP-AF score and epicardial adipose tissue thickness for early recurrence after catheter ablation in atrial fibrillation patients.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia globally, associated with a significant burden of stroke, heart failure, and reduced quality of life. Early recurrence after catheter ablation for AF remains a common and challenging issue. Objective: Our aim was to investigate the correlation between epicardial adipose tissue (EAT) thickness and early recurrence after catheter ablation in patients with AF, and to evaluate the incremental predictive value of EAT thickness when combined with the CAAP-AF score. Methods: A total of 56 AF patients who underwent catheter ablation between March 2023 and November 2023 at Zhangzhou Affiliated Hospital of Fujian Medical University were included in this study. The CAAP-AF score was calculated, and EAT thickness was measured for each patient. Patients were divided into two groups based on follow-up outcomes: early recurrence and no recurrence. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive value of the CAAP-AF score, EAT thickness, and their combination for early recurrence after catheter ablation. Results: Early recurrence occurred in 13 patients, while 43 patients had no recurrence. Multivariate logistic regression analysis demonstrated that both the CAAP-AF score (OR = 2.10, 95% CI: 1.09-4.05, Conclusion: Both the CAAP-AF score and EAT thickness are independent risk factors for early recurrence after catheter ablation in AF patients. Combining these two parameters enhances the predictive accuracy for early recurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.